| |
|
|
|
Entera Bio Ltd  
|
|
1.65 -0.04 (-0.02%) |
08-10 14:50 |
|
Open: |
1.65 |
Pre close: |
1.69 |
Target:
|
3.04
|
|
High: |
1.7 |
Low: |
1.63 |
Resistance:
|
2.60
3.21
|
|
Volume: |
120,009 |
Market Cap: |
30M |
Support:
|
1.61
1.34
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.70
|
MACD |
MACD(12,26):
|
-0.06  |
|
MA(20): |
1.82 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
1.99  |
Stochastic Oscillator |
%K(14,3):
|
4.38 |
|
MA(250): |
2.34 |
%D(3): |
5.63 |
|
Average Volume(K) |
3-Month: |
72803
|
52-Week |
High:
|
3.40 |
|
10-Days: |
22081 |
Low: |
1.59 |
|
RSI |
RSI(14):
|
40.96 |
Change(%): |
-31.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.778 |
Return on Equity (ttm) |
-121.3 |
Shares Out. (M) |
18.23 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-52.9 |
Shares Float (M) |
8.85 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
41.22 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
10.55 |
|
Forward EPS |
1.310 |
Gross Profit (p.s.) |
0.001 |
Shares Short (K) |
24 |
|
Book Value (p.s.) |
0.550 |
EBITDA (p.s.) |
-0.612 |
P/E |
-2.12 |
|
Sales Per Share |
0.015 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.64 |
P/S |
108.20 |
|
Operating Margin |
-4049.64 |
Levered Free Cash Flow
(M) |
-2.81 |
P/CF |
-3.12 |
|
|
|
|
|
|
